EU Drug Safety Actions Speeded Up By New Legislation, Says Commission
Executive Summary
The European Commission reports that new regulatory tools made available under the revised pharmacovigilance legislation have allowed drug safety issues to be detected and acted upon more rapidly, and that further improvements to the system are in the pipeline.